爱尔眼科(300015) - 2017 Q1 - 季度业绩预告

Financial Performance - The company expects a net profit of approximately RMB 15,423.63 million to RMB 16,016.85 million for Q1 2017, representing a year-on-year growth of 30%-35%[3] - The net profit for the same period last year was RMB 11,864.33 million[3] - The increase in net profit is attributed to the company's enhanced brand influence, expanded operational scale, and improved operational efficiency[5] - The estimated impact of non-recurring gains and losses on net profit is around RMB 8 million[7] - The financial data presented is based on preliminary calculations by the company's finance department and will be detailed in the Q1 2017 report[7] - The performance forecast has not been audited by a registered accountant[4] - The reporting period for the performance forecast is from January 1, 2017, to March 31, 2017[3] - The company has maintained continuous growth in both operating revenue and net profit during the reporting period[5] - The performance forecast indicates a positive trend in the company's financial health compared to the previous year[3] Investor Guidance - The company emphasizes the importance of rational investment and risk awareness for investors[7]